In September, Replit completed a $250M funding round that gave it a $3B valuation. That round was led by Prysm Capital and ...

With a new tool called Mobile Apps by Replit, users can describe their idea, let Replit do its thing, and then test the app on their iPhones.

Replit’s new feature generates iOS apps from text prompts, integrates monetization, and streamlines App Store publishing - ...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Replit is racing to turn its AI coding tools into a full-stack software factory, and investors appear ready to bankroll that ...